Generic Pemigatinib for FGFR2-Fusion Cholangiocarcinoma

Pemigatinib is this neat inhibitor for those fibroblast growth factor receptor (FGFR) family thingys. It’s mainly used to help with cholangiocarcinoma when there’s this FGFR2 fusion thing going on. Its trick is to block that FGFR signaling action.

See, it’s essential because it helpsFGFR2 fusion positive cholangiocarcinomas keep growing and getting all progressed. They’ve got three tablets – 4.5, 9, and 13.5 mg. The standard dosing for pemigatinib is 13.5 mg every single day for a straight two weeks every month.

The stuff comes in bottles with 14 tablets inside each one. It’s meant to go the whole month on those 14 tablets if you’re taking the 13.5 mg dose every day. Since each bottle’s got enough for a full two weeks, that’s what they’re meant to last.